NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global movement is preparing to shift the narrative from early detection to the stark, often-overlooked reality of those living with the disease’s terminal form. On October 13, 2026, the #LightUpMBC campaign will see more than 325 iconic landmarks across all 50 U.S. states and 20 countries illuminate in a triad of teal, green, and pink. This synchronized display of light serves as a powerful tribute to the lives lost to metastatic breast cancer (MBC) and a call to action to fund the research necessary to transform a terminal diagnosis into a manageable chronic condition.
Main Facts: The Global Scope of #LightUpMBC 2026
The #LightUpMBC campaign, spearheaded by METAvivor Research and Support, has evolved into one of the most significant visual advocacy events in the oncology space. This year’s coordination involves 195 cities worldwide, reaching from the skyscrapers of New York City to the coastlines of the Philippines and the historic bridges of Scotland.
Metastatic breast cancer, also categorized as Stage 4, occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to distant organs—most commonly the bones, liver, lungs, or brain. Despite advancements in screening and early-stage treatment, MBC remains incurable. The #LightUpMBC initiative seeks to highlight this discrepancy, emphasizing that while "pink" awareness has successfully promoted early detection, the 30% of early-stage patients who eventually metastasize require a different level of scientific focus and funding.
The colors chosen for the illumination carry deep symbolic weight: teal represents healing and community; green symbolizes the triumph of spring over winter and the hope for renewal; and pink signifies the disease’s origins in the breast. On the evening of October 13, the campaign will culminate in "#LightUpMBC Live," a virtual broadcast starting at 8 p.m. ET. The program will feature a blend of patient testimonials, scientific updates from leading oncologists, and performances by Broadway stars and award-winning musicians.
Chronology: From a Single Bridge to a Global Network
The history of #LightUpMBC is a testament to the power of grassroots advocacy. The movement was born from the vision of Jessica Moore, a young woman diagnosed with MBC who recognized a void in the public’s understanding of the disease. Moore’s goal was modest: to see one local landmark lit in MBC awareness colors to spark a conversation.
Following her passing at the age of 36, her best friend, Laura Inahara, took up the mantle. In 2017, Portsmouth’s Memorial Bridge in New Hampshire became the first landmark to officially "light up" for the cause. What began as a local tribute quickly resonated with a global community of patients and caregivers who felt sidelined by traditional breast cancer marketing.
By 2020, despite the challenges of a global pandemic, the campaign transitioned into a digital-first powerhouse, launching the "Live" broadcast component to connect isolated patients. By 2023, the campaign had surpassed $2 million in funds raised. Now, in 2026, the movement has reached a record-breaking scale, having raised over $2.7 million to date. The inclusion of international landmarks like the Mactan-Cebu Airport in the Philippines and Ness Bridge in Scotland underscores the universal nature of the metastatic struggle.
Supporting Data: The Urgent Need for MBC Research
The statistics surrounding metastatic breast cancer provide a sobering backdrop to the October 13 festivities. According to data from the National Cancer Institute and SEER (Surveillance, Epidemiology, and End Results), an estimated 42,670 people in the United States are expected to die from breast cancer in 2026 alone. This equates to approximately 117 deaths every single day.
A critical point of contention within the advocacy community is the "funding gap." While billions of dollars are raised annually for breast cancer, historical data suggests that only 7% to 10% of total research funding is directed toward metastatic disease—the only form of breast cancer that kills.
METAvivor Research and Support was founded specifically to address this imbalance. Unlike many other organizations, 100% of the net proceeds from #LightUpMBC and other METAvivor initiatives go directly to funding Stage 4 research grants. These grants are awarded through a rigorous peer-review process that includes both scientific experts and patient advocates, ensuring that the research funded has the highest potential for immediate clinical impact.
The medical reality for these patients is one of perpetual treatment. For a person with MBC, there is no "finishing" chemotherapy or "ringing the bell" to signify the end of cancer. Treatment continues for the rest of the patient’s life, often involving a rotating sequence of therapies as the cancer inevitably develops resistance to one drug, forcing a move to the next. The goal of current research is to extend these "lines of therapy," allowing patients to live for years or even decades with a high quality of life.
Official Responses: Voices from the Frontlines
The leadership behind the 2026 campaign emphasizes that while the lights are beautiful, the mission is strictly biological.
Dr. Kelly Shanahan, a physician and the METAvivor Board President, provides a unique perspective as both a doctor and a patient. Diagnosed with MBC in 2013, she has defied the average survival statistics. “When I was diagnosed, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important these days because it focuses solely on the stage of the disease that is actually taking lives. #LightUpMBC is the biggest contributor to this research and a vital way to unify our community.”
Laura Inahara, the founder of the campaign, reflected on the legacy of her friend Jessica Moore. “Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love,” Inahara said. “It has grown into a platform that teaches patients how to advocate for themselves while raising millions for critical research.”
The 2026 live broadcast will be hosted by Tami Eagle Bowling, a high-profile advocate who has lived with MBC for 11 years, and Broadway’s Kara Lindsay. Bowling, who also serves as the Campaign Director, noted the importance of the "Live" element: “We are bringing the stories of patients directly from the foot of these illuminated landmarks into the homes of viewers. It’s about visibility for a population that has long felt invisible.”
Implications: Changing the Paradigm of Stage 4 Cancer
The #LightUpMBC campaign represents a broader shift in how society views terminal illness. By demanding specific recognition and funding for Stage 4, METAvivor is challenging the "survivorship" narrative that often excludes those who will never be cancer-free.
The implications of this movement extend into the legislative and pharmaceutical realms. Increased public awareness of MBC has historically led to more inclusive clinical trial designs and faster FDA approval for breakthrough therapies like antibody-drug conjugates (ADCs) and PARP inhibitors. These treatments have already begun to move the needle on life expectancy for various subtypes of metastatic disease, including the notoriously difficult-to-treat Triple Negative Breast Cancer (TNBC).
Furthermore, the campaign addresses the psychological impact of the "Pink Ribbon" culture. Many MBC patients report feeling a sense of "failure" or isolation during October when the focus is heavily on "beating" cancer through early detection. #LightUpMBC provides a dedicated space—National Metastatic Breast Cancer Awareness Day—to acknowledge that for many, the battle is not about a cure, but about time.
As One World Trade Center, the Willis Tower, and hundreds of other structures turn teal, green, and pink this October 13, the message is clear: awareness is the first step, but research is the only path to survival. The global community is invited to participate by photographing these landmarks and sharing them using the hashtags #LightUpMBC and #METAvivor, ensuring that the 117 lives lost each day are remembered through action, not just symbols.
For more information on participating landmarks, to view the livestream, or to make a donation to metastatic research, visit www.lightupmbc.org.
About the Author
